Journal Article Summary
The article discusses the potential risk of hypomania induced by atomoxetine, a medication used to treat adult attention deficit hyperactivity disorder (ADHD), in patients with bipolar disorder (BD). This topic is significant because managing ADHD in individuals with BD can be challenging, as certain medications may trigger manic episodes. The authors highlight that while previous studies suggested a low risk of hypomania when atomoxetine is used with mood stabilizers, this case report presents evidence that such risks can still occur, even in patients who are stable on their bipolar treatment.
The study centers on a 22-year-old male diagnosed with both BD and borderline personality disorder (BPD), who was stable on mood stabilizers before starting atomoxetine for ADHD. After increasing the atomoxetine dosage, the patient exhibited symptoms of hypomania, including increased talkativeness, irritability, and reduced need for sleep. These symptoms were assessed using the Young's Mania Rating Scale and resolved within a few days after discontinuing atomoxetine, indicating a probable link between the medication and the hypomanic episode.
The authors note several limitations, including the lack of randomized controlled trials on ADHD treatment in adults with BD and the need for more research on the effects of atomoxetine in this population. They emphasize the importance of monitoring patients closely for hypomanic symptoms when prescribing atomoxetine, even if they are stabilized on mood stabilizers. Patients and caregivers should discuss any concerns about ADHD treatment options and the potential risks of hypomania with their healthcare providers to ensure safe and effective management of both conditions.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Kumar Vijaya, Varambally Shivarama. Atomoxetine Induced Hypomania in a Patient with Bipolar Disorder and Adult Attention Deficit Hyperactivity Disorder. Indian Journal of Psychological Medicine 2017. DOI: 10.4103/0253-7176.198954. PMID: 28250566. PMCID: PMC5329999.
Featured Pill Pals Product
Atomoxetine 60 mg Capsules --- Generic for Strattera --- Glenmark
Atomoxetine 60 mg Capsules — Generic for Strattera — Glenmark is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
